Patents Assigned to Nanoveson, LLC
  • Nanoveso™: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases
    Patent number: 9186343
    Abstract: A method of treatment of liver diseases and comorbid diseases is disclosed wherein an oral dose of lipids in an amount effective to trigger the release of cholecystokinin (CCK) into the duodenum to generate a major release of bile phospholipids from remodeled stores of triglycerides (TAG) in the liver, is administered to a patient in need thereof, thereby causing the formation of sequestered and aggregated mixed micelles and vesicles (SAMMVs) in the intestines of the patient which are then eliminated via the bowels of the patient.
    Type: Grant
    Filed: December 24, 2008
    Date of Patent: November 17, 2015
    Assignee: Nanoveson, LLC
    Inventor: David K. Barker